Evaporation-reducing Culture Condition Increases the Reproducibility of Multicellular Spheroid Formation in

Viswanath Das1, Tomáš Fürst1, Soňa Gurská1

  • 1Institute of Molecular and Translational Medicine, Palacky University in Olomouc.

Insights

This study improves the liquid-overlay method for generating multicellular tumor spheroids (MCTSes), enhancing reproducibility and scalability for anti-cancer drug screening. A new software tool aids in evaluating MCTS features post-treatment.

Area of Science:

  • Oncology
  • Drug Discovery
  • Biotechnology

Background:

  • Multicellular tumor spheroids (MCTSes) are valuable in vitro models for mimicking solid tumor physiology in anti-cancer drug discovery.
  • The liquid-overlay method using agarose is a cost-effective technique for MCTS generation but faces challenges in scalability and reproducibility for high-throughput screening.
  • Limitations include agarose coating issues, inconsistent spheroid formation, and edge effects in microtiter plates (MPs) due to medium evaporation.

Purpose of the Study:

  • To present technical improvements to the liquid-overlay method for generating MCTSes.
  • To enhance the scalability and reproducibility of uniform MCTS formation for drug screening.
  • To introduce a software tool for semi-automatic evaluation of MCTS features after drug treatment.

Main Methods:

  • Detailed technical modifications to the standard liquid-overlay MCTS culture technique.
  • Implementation of strategies to mitigate edge effects and improve MCTS uniformity.
  • Development of a universally applicable, semi-automatic software tool for MCTS analysis.

Main Results:

  • Achieved increased scalability and reproducibility in generating uniform multicellular tumor spheroids.
  • Successfully addressed limitations associated with agarose coating and edge effects in microtiter plates.
  • Demonstrated the utility of the developed software for efficient MCTS feature evaluation post-drug treatment.

Conclusions:

  • The refined liquid-overlay technique offers a more robust and scalable approach for MCTS generation in anti-cancer drug development.
  • The integrated software tool facilitates standardized and efficient analysis of MCTS responses to drug candidates.
  • These advancements improve the reliability of in vitro tumor models for lead optimization and target validation.

Related Concept Videos